Mechanism of action of phthalazinone derivatives against rabies virus - Fondation pour la Recherche Médicale Accéder directement au contenu
Article Dans Une Revue Antiviral Research Année : 2024

Mechanism of action of phthalazinone derivatives against rabies virus

Résumé

Rabies, a viral zoonosis, is responsible for almost 59,000 deaths each year, despite the existence of an effective post-exposure prophylaxis. Indeed, rabies causes acute encephalomyelitis, with a case-fatality rate of 100 % after the onset of neurological clinical signs. Therefore, the development of therapies to inhibit the rabies virus (RABV) is crucial. Here, we identified, from a 30,000 compound library screening, phthalazinone derivative compounds as potent inhibitors of RABV infection and more broadly of Lyssavirus and even Mononegavirales infections. Combining in vitro experiments, structural modelling, in silico docking and in vivo assays, we demonstrated that phthalazinone derivatives display a strong inhibition of lyssaviruses infection by acting directly on the replication complex of the virus, and with noticeable effects in delaying the onset of the clinical signs in our mouse model.
Fichier principal
Vignette du fichier
1-s2.0-S0166354224000469-main.pdf (5.28 Mo) Télécharger le fichier
Origine Publication financée par une institution
licence

Dates et versions

hal-04582877 , version 1 (22-05-2024)

Licence

Identifiants

Citer

Victoire Perraud, Bart Vanderhoydonck, Guillaume Bouvier, Guilherme Dias de Melo, Amuri Kilonda, et al.. Mechanism of action of phthalazinone derivatives against rabies virus. Antiviral Research, 2024, 224, pp.105838. ⟨10.1016/j.antiviral.2024.105838⟩. ⟨hal-04582877⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More